Sign inGet started

Humer Kristian

Insider CIK 1872280 · VRDN CFO and CBO · FDMT Chief Financial Officer · FHTX Chief Financial Officer · SNSE Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
FDMT 4D Molecular Therapeutics, A Award deriv2025-12-092025-12-11480,000— $0480,000SEC↗
SNSE Sensei Biotherapeutics, In A Award deriv2025-05-212025-05-2319,000— $019,000SEC↗
FHTX Foghorn Therapeutics Inc. A Award deriv2025-01-222025-01-24120,000$4.37 $524.4K120,000SEC↗
SNSE Sensei Biotherapeutics, In A Award deriv2024-06-112024-06-1319,000— $019,000SEC↗
FHTX Foghorn Therapeutics Inc. A Award deriv2024-04-162024-04-17275,000$6.03 $1.66M275,000SEC↗
SNSE Sensei Biotherapeutics, In A Award deriv2023-07-102023-07-1214,550— $014,550SEC↗
SNSE Sensei Biotherapeutics, In A Award2023-07-102023-07-124,466— $08,932SEC↗
VRDN Viridian Therapeutics, Inc A Award deriv2023-02-082023-02-10108,000— $0108,000SEC↗
SNSE Sensei Biotherapeutics, In A Award deriv2022-06-102022-06-1414,550— $014,550SEC↗
SNSE Sensei Biotherapeutics, In A Award2022-06-102022-06-144,466— $04,466SEC↗
VRDN Viridian Therapeutics, Inc A Award deriv2022-02-022022-02-0390,000— $090,000SEC↗
VRDN Viridian Therapeutics, Inc A Award deriv2021-12-312022-01-03121,371— $0121,371SEC↗
SNSE Sensei Biotherapeutics, In A Award deriv2021-07-302021-08-0216,667— $016,667SEC↗
VRDN Viridian Therapeutics, Inc A Award deriv2021-07-262021-07-27360,000— $0360,000SEC↗